A detailed history of State Of Wyoming transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, State Of Wyoming holds 12,310 shares of TBPH stock, worth $122,607. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,310
Previous 4,951 148.64%
Holding current value
$122,607
Previous $41,000 141.46%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.66 - $10.25 $56,369 - $75,429
7,359 Added 148.64%
12,310 $99,000
Q2 2024

Aug 14, 2024

BUY
$8.29 - $9.92 $41,043 - $49,113
4,951 New
4,951 $41,000
Q2 2022

Aug 15, 2022

BUY
$8.41 - $10.34 $35,952 - $44,203
4,275 New
4,275 $39,000

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $665M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.